Clinical Trials Browser

Phase 1/2 × Interventional × Advanced Ovarian Cancer × Clear all

NCT01989546 2021-02-23

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Phase 1/2 Completed

9 enrolled 11 charts

BreastGynecologicOther solid neoplasm

Advanced Ovarian Cancer